Tian W, Niu L, Shi Y#, Li S, Zhou R#. First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis. Ther Adv Med Oncol. 2024 May 30;16:17588359241255613. doi: 10.1177/17588359241255613. PMID: 38827178 (JCR2区 IF=4.9)
发布时间：2026-10-01
点击次数：
是否译文：否
上一条： Chu X, Tian W, Ning J, Zhou R#. Efficacy and Safety of Personalized Optimal PD-(L)1 Combinations in Advanced NSCLC: A Network Meta-Analysis. J Natl Cancer Inst. 2024 Oct 1;116(10):1571-1586. (JCR1区 IF=10.3)
下一条： Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, Zhai Z, Tanzhu G, Yang J, Zhou R. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther. 2024 Jul 5;9(1):170. (JCR1区 IF=81.2)